пятница, 11 февраля 2011 г.

Men: Soda, Unhealthy Lifestyle Affect Fertility

Danish researchers have found that men who drink a quart of soda or more each day had a 30% lower sperm count than men who did not consume soft drinks. Those men were also more likely to live more unhealthy lifestyles that can lead to reduced fertility.
Dr. Tina Kold Jensen of Rigshospitalet in Copenhagen, Denmark and colleagues studied more than 2,500 young men. The majority of the men didn’t drink cola on a regular basis, and also lived more healthful lifestyles overall. Those men had a sperm count of 50 million sperm per millimeter of semen. Just under 100 men drank sodas regularly and also had a tendency to eat more fast food and less fruit and vegetables. Those men had only 35 million sperm per millimeter.
The counts are still considered within the normal limits, according to the World Health Organization, however, men with fewer sperm generally have a higher risk of being infertile.
The researchers did not find an association with the caffeine content of the soda and the decrease in sperm count. Coffee and tea did not lead to the same effect in this population sample, and previous studies have found conflicting results. Instead they felt other ingredients in the beverage, or because it was one factor in an overall unhealthy lifestyle, were the primary factors.
Many studies have shown an association with a healthy, well-balanced diet in the preservation of reproductive health for both men and women. A 2009 Spanish study published in the journal Fertility and Sterility found that men who ate more dairy and meat, and less fruits and vegetables, were more likely to have poor semen quality.
Infertility is a common problem, affecting an estimated 6 million American couples. Men who are ready to start a family should follow a healthy diet and exercise program to include:
Eat plenty of foods rich in vitamin C and other antioxidants. These nutrients help prevent sperm defects and boost its motility (movement). An 8-ounce glass of orange juice contains about 124 milligrams of C. Aim for at least 90 mg a day.
Oysters are not just an old-wives tale. Several studies show that even short-term zinc deficiencies can reduce semen volume and testosterone levels. Men need 11 milligrams of zinc per day and great sources include oysters (six medium oysters have 16 mg), extra-lean beef tenderloin (a 3-ounce serving has 4.8 mg), baked beans (a 1-cup serving contains 3.5 mg), and dark chicken meat (2.38 mg per 3 ounces).
Both Mom and Dad need folic acid. Studies suggest that men with low levels of this key B vitamin — the same one women need to reduce the baby's risk for neural tube birth defects — have lower sperm counts. The daily minimum is 400 micrograms and excellent sources include fortified breakfast cereals, leafy greens, legumes, and orange juice.
Boost your calcium and vitamin D. Consuming 1,000 mg of calcium and 400 IU (10 micrograms) of vitamin D each day may improve a man's fertility, according to research from University of Wisconsin at Madison. Good calcium sources include skim milk (an 8-ounce glass has 302 mg) and yogurt (1 cup of plain yogurt contains 415 mg of calcium).You can get vitamin D from milk (an 8-ounce glass has 98 IU) and salmon (a 3-ounce serving has 360 IU).
Limit or eliminate alcohol. While an occasional drink is generally considered safe, studies show that daily wine, beer, or hard liquor consumption can reduce testosterone levels and sperm counts and raise the number of abnormal sperm in your ejaculate. Other research has shown that alcohol is also bad for baby – men who drank the equivalent of two alcoholic beverages a day in the month before conception have babies who weigh an average of 6.5 ounces less than other babies. While that may not seem like a lot, babies with low birth weight can have significant medical conditions.
Exercise and control your weight. Both of these factors have reproductive repercussions, so strive for 30 minutes a day of moderate physical activity in addition to the healthy diet to maintain weight, or even lose a couple of pounds.

понедельник, 13 декабря 2010 г.

Consumers Warned Not To Use Erectile Dysfunction Treatment Oyster Plus

Erectile Dysfunction Treatment Oyster Plus
Health Canada is advising consumers not to use Oyster Plus was an approved sexual enhancement/erectile dysfunction product in Malaysia due to concerns about possible side-effects.
The Malaysian Ministry of Health cancelled the registration of the product Oyster Plus due to the presence of tadalafil, a prescription drug used for the treatment of erectile dysfunction that should only be taken under the guidance of a health professional.
Possible Side Effects � � � � � �
Unsupervised use of tadalafil by patients with heart disease can result in serious cardiovascular side-effects such as sudden cardiac death, heart attack, stroke, hypertension, chest pain and abnormal heartbeat.
Additionally, use of tadalafil may be associated with other side-effects including temporary vision loss, seizure, prolonged erection, headache, flushing, nasal congestion and abdominal pain. Tadalafil should not be used by individuals taking any type of nitrate drug (e.g., nitroglycerine) due to the risk of developing potentially life-threatening low blood pressure.

среда, 8 декабря 2010 г.

Consumers Advised Not To Use The Following Products For Treatment Of Erectile Dysfunction

Health Canada is advising consumers not to use the following product for treatment of erectile dysfunction due to concerns about possible side-effects.
Product Names are Power 58 Extra, Platinum Power 58 Extra, Enhanix New Extra Men's Formula, Valentino, King Power Oral Solution, and Stretch Up Capsules.
The products contain sildenafil and vardenafil analogues.
Sildenafil and vardenafil are prescription medications indicated for treatment of erectile dysfunction. They should only be used under the supervision of a health care professional.
Possible Side Effects associated with both sildenafil citrate and vardenafil hydrochloride include headache, flushing, gastrointestinal disorders, penile tissue damage, visual disturbances, and inflammation of the mucous membrane of the nose.
Products containing sildenafil citrate or vardenafil hydrochloride should also not be used by anyone taking a nitrate medication, as the combination could lead to potentially life-threatening low blood pressure.

пятница, 3 декабря 2010 г.

Men with Erectile Dysfunction Have Increased Risk for Cardiovascular Events

Erectile Dysfunction and Heart

Men with erectile dysfunction have a higher risk of subsequent cardiovascular events such as heart attack, stroke, and angina, according to a study in the December 21 issue of JAMA.
More than 10 million men in the United States are affected by erectile dysfunction (ED), with an estimated 100 million men affected worldwide, according to background information in the article. The risk of erectile dysfunction is related to many factors, including age, smoking, diabetes, heart disease, depression, and hypertension. Because cardiovascular disease and erectile dysfunction share etiologies as well as pathophysiology (endothelial dysfunction) and because of evidence that degree of erectile dysfunction correlates with severity of cardiovascular disease, it has been postulated that erectile dysfunction is a sentinel symptom in patients with cardiovascular disease.
Ian M. Thompson, M.D., of the University of Texas Health Science Center at San Antonio, and colleagues studied a group of men who were assessed for ED and subsequent cardiovascular disease over the course of 7 years. The study included men aged 55 years or older who were randomized to the placebo group (n = 9,457) in the Prostate Cancer Prevention Trial at 221 U.S. centers. Participants were evaluated every 3 months for cardiovascular disease and erectile dysfunction between 1994 and 2003. In analysis, factors at study entry taken into account included age, body mass index, blood pressure, serum lipids, diabetes, family history of heart attack, race, smoking history, current use of antihypertensive medication, physical activity, and quality of life.
Of the 9,457 men randomized to placebo, 8,063 (85 percent) had no cardiovascular disease at study entry; of these men, 3,816 (47 percent) had erectile dysfunction at study entry. Among the 4,247 men without erectile dysfunction at study entry, 2,420 men (57 percent) reported incident erectile dysfunction after 5 years. After adjustment, incident erectile dysfunction was associated with a 25 percent increased risk for subsequent cardiovascular events during study follow-up. For men with either incident or prevalent erectile dysfunction, the increased risk was 45 percent.
"Our analysis of men in the placebo group of this study demonstrates the substantial association between incident as well as prevalent erectile dysfunction and subsequent cardiovascular disease, including angina, myocardial infarction, stroke, and transient ischemic attack," the authors write.
"The implications of this study are substantial. With the availability of effective pharmacotherapy, an increasing number of men are seeking care for erectile dysfunction. It is estimated that more than 600,000 men aged 40 to 69 years in the United States develop erectile dysfunction annually. Our data suggest that the older men in this group have about a 2-fold greater risk of cardiovascular disease than [younger] men without erectile dysfunction. With 70 percent to 89 percent of sudden cardiac deaths occurring in men and with many men not having regular physical examinations, this analysis suggests that the initial presentation of a man with erectile dysfunction should prompt the evaluating physician to screen for standard cardiovascular risk factors and, as appropriate, initiate cardioprotective interventions," they write.

понедельник, 29 ноября 2010 г.

Do Not Consume Sexual Dysfunction Capsules With Undeclared Drug

Hong Kong Department Of Health appealed to members of the public again not to consume various capsules claimed to treat male impotence, following Hospital Authority (HA)’s notification of a second cluster of six more non-diabetic men who were retrospectively found to have residues of the sugar-lowering drug glibenclamide in their clinical specimens (including urine).
This now brings the number of patients affected by such category of products to a total of 10.
A spokesman for DH said that the six men, aged between 53 and 86, had been admitted to hospitals with symptoms of low blood sugar like dizziness, sweating and collapse between December 2007 and January 2008. Five of them have been discharged after treatment while one is still in hospital.
DH’s investigation showed two of them had consumed yellow capsules labeled as ??? and red/pink capsules named as "Nangen" brought from a hawker in Yuen Long and a shop in Shenzhen respectively.
Of the first cluster of four cases reported to DH on February 1, one had passed away and the case has been submitted to Coroner’s Court for inquiry; one is still in intensive care unit; and the remaining two have been discharged.
Investigations into the sources of all cases are ongoing with Police involvement.
"DH had set up clinical case surveillance with HA and all 12 private hospitals and no new case has been detected since February 1," the spokesman said.
"DH had inspected more than 220 pharmacies and retail shops throughout the territory with an emphasis in North District, where one incriminated shop named Lung Sang Group Ginseng Antler and Sea Product Company in Sheung Shui is located," he added.
During the operation, some 130 red/yellow capsules similar to the one taken by a patient were seized from the Sheung Shui retail shop. Laboratory tests revealed the presence of impotent treatment drugs sildenafil and tadalafil and a high level of oral hypoglycaemic drug glibenclamide. If consumed, it could result in serious health consequences or even death.
Under the Pharmacy and Poisons Ordinance, products containing glibenclamide must be registered before sale and can only be sold on a doctor’s prescription and under the supervision of a pharmacist.
"Currently, similar efforts in other districts are going," the spokesman said.
He said that letters have also been issued to all doctors and private hospitals to alert them of the incidents.
"Today, similar alert will be issued to medicines traders and Chinese medicines practitioners as well," he said.
DH also informed the State Food and Drug Administration of Mainland and Department of Health of Macau for follow-up, as the capsules seized in the Sheung Shui shop were allegedly purchased from a Mainland agent, the spokesman added. "We have also informed the drug administration of Shenzhen of the incidents."
The spokesman reiterated that members of the public and the trade who have in their possession similar products are urged to stop consuming or trading them immediately.
They should dispose of the products or submit it to the Department’s Pharmaceutical Service at 3/F, Public Health Laboratory Centre, 382 Nam Cheong Street, Kowloon during office hours. If they have any enquiry, there is a hotline no. 2572 2068 which operates during office hours.
The spokesman urged people who had problems of sexual dysfunction to consult healthcare professionals for appropriate advice.
He further urged all retailers not to buy drugs from unknown sources, as the efficacy, safety and quality of such could not be assured.

среда, 24 ноября 2010 г.

Therapy Lets Prostate Cancer Patients Avoid Erectile Dysfunction

Erectile dysfunction or impotence among men without prostate cancer is most commonly caused by a problem in the blood vessels.Erectile Dysfunction and Prostate Cancer
Researchers at the University of Michigan Comprehensive Cancer Center are using innovative planning techniques to help men with prostate cancer avoid erectile dysfunction after radiation treatment.
By using MRI scans in addition to CT scans, radiation oncologists can identify the blood vessels that control erectile function and plan treatment to target the prostate more precisely, sparing those nearby vessels. Results from an initial study with 25 patients appear in the January issue of the International Journal of Radiation Oncology Biology Physics.
Some 230,000 men were diagnosed with prostate cancer in 2004. While it's more common in older men, a growing number of men are being diagnosed in their 50s.
"As we treat younger men, erectile function is an important concern. We're often treating men in their 50s, and this is a very important issue for them. Most of the men I see are going to be cured. Once you start curing cancers at an extremely high rate, then the focus moves to quality of life," says Patrick W. McLaughlin, M.D., clinical professor of Radiation Oncology at the University of Michigan Medical School and director of Providence Hospital Radiation Oncology, with cancer centers in Southfield and Novi, both affiliated with the U-M Comprehensive Cancer Center.
Treatment for prostate cancer can involve surgery to remove the prostate or radiation therapy. During surgery, the nerves that control erectile function may be severed - which has led to new surgical techniques to avoid cutting those nerves.
But doctors are less sure what causes erectile dysfunction after radiation therapy. Erectile dysfunction among men without prostate cancer is most commonly caused by a problem in the blood vessels, and doctors do know that radiation causes obstruction of the vessels that fall within the treatment area. Using that as a starting point, the U-M team began investigating radiation-related erectile dysfunction as a blood vessel problem.
Typically, radiation oncologists rely on a CT scan to identify the prostate and plan treatment. But because of limitations in the CT scan, the images do not show the bottom of the prostate. Doctors instead estimate where the prostate ends, based on average distance from identifiable structures. The U-M study, using MRI in addition to CT scans to get a better picture of the whole prostate, found the distance between the prostate and the penile bulb ranged from 0.5 cm to 2.0 cm.
"We condemned one of the common tricks people try to use. By assuming an average distance of 1.5 cm between the prostate and the penile bulb, either you're going to treat way more than you need to or you're going to miss the prostate," McLaughlin says.
By taking the additional imaging, the U-M team was able to plan treatment to include the entire prostate but avoid the critical blood vessels below. Preliminary results suggest that avoiding the vessels prevents erectile dysfunction.